Related Experiment Videos
Operative treatment in massive peptic ulcer bleeding
Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1985
Summary
Surgical intervention rates for bleeding peptic ulcers decreased, but mortality in older operated patients remains high. Improved medical treatments have lowered overall mortality in this age group.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Clinical Medicine
Background:
- Peptic ulcer disease is a common condition with significant morbidity and mortality.
- Bleeding peptic ulcers necessitate careful management strategies, balancing surgical and medical interventions.
- Trends in surgical intervention and outcomes for bleeding peptic ulcers require ongoing evaluation.
Purpose of the Study:
- To provide guidelines for surgical intervention in patients with bleeding peptic ulcers.
- To analyze the trends in surgical rates for bleeding peptic ulcers.
- To evaluate the mortality rates associated with surgical and medical management of bleeding peptic ulcers, particularly in elderly patients.
Main Methods:
- Retrospective analysis of patient data.
- Review of surgical intervention rates and outcomes.
- Comparison of mortality rates between surgical and medical treatment groups.
- Analysis stratified by age, focusing on patients over 60 years.
Main Results:
- A decrease in the rate of surgical operations for bleeding peptic ulcers was observed between 1976 and 1983 in Göteborg.
- Mortality rates for patients over 60 years who underwent surgery for bleeding peptic ulcers remained high, approximately 30%.
- Significant improvements in medical treatment led to a reduction in overall mortality for patients over 60 years, from 23% to 11%.
Conclusions:
- While surgical intervention rates for bleeding peptic ulcers have declined, surgical outcomes in elderly patients remain a concern.
- Advancements in medical management have proven effective in reducing mortality for bleeding peptic ulcers in older adults.
- Guidelines for surgical intervention should consider the evolving landscape of medical treatments and patient-specific risk factors, especially in the elderly population.